Was anything negative for Altimmune Inc (ALT) stock last session?

While Altimmune Inc has underperformed by -0.72%, investors are advised to look at stock chart patterns for technical insight. Within its last year performance, ALT rose by 7.68%, with highs and lows ranging from $11.16 to $3.55, whereas the simple moving average jumped by 4.86% in the last 200 days.

On February 28, 2025, William Blair started tracking Altimmune Inc (NASDAQ: ALT) recommending Mkt Perform. A report published by Stifel on January 08, 2025, Initiated its previous ‘Buy’ rating for ALT. UBS also rated ALT shares as ‘Buy’, setting a target price of $26 on the company’s shares in an initiating report dated November 12, 2024. Goldman initiated its ‘Neutral’ rating for ALT, as published in its report on January 24, 2024. Goldman’s report from March 22, 2023 suggests a price prediction of $6 for ALT shares, giving the stock a ‘Neutral’ rating. Goldman also rated the stock as ‘Buy’.

Analysis of Altimmune Inc (ALT)

One of the most important indicators of Altimmune Inc’s future performance is equity, which can be evaluated using several well-rounded types of analysis and research techniques. The goal here is to ensure that your current return on equity of -57.28% is sufficient for you to turn a profit off your investment. Taking into account the quick ratio of the company, currently set at 15.82, you can see that the company can cover any debts it may have, which can easily be seen in the annual report of the company.

For any stock, average volume can also provide valuable insight into volatility, and ALT is recording 2.73M average volume. On a monthly basis, the volatility of the stock is set at 4.52%, whereas on a weekly basis, it is put at 5.74%, with a gain of 15.46% over the past seven days. Furthermore, long-term investors anticipate a median target price of $22.38, showing growth from the present price of $6.87, which can serve as yet another indication of whether ALT is worth investing in or should be passed over.

How Do You Analyze Altimmune Inc Shares?

Along with the fundamentals, it is also important to consider how many employees own shares of the company. This is because the values should be in line with investors’ expectations. As such, the current holdings of company stock inside the company are set at 1.04%. This can enable you to see the extent to which executives own the company’s stock. As opposed to executive stock, institutional ownership accounts for 47.38% of the company’s shares, contributing to an indication of company value, since large shareholders may signify strength within the organization.

ALT shares are owned by institutional investors to the tune of 47.38% at present.

Hot this week

Investing in Starz Entertainment Corp (STRZ) might be an excellent idea, but the stock is currently overvalued/undervalued

While Starz Entertainment Corp has underperformed by -4.06%, investors...

Can you now get a good deal on Purple Biotech Ltd ADR’s shares?

While Purple Biotech Ltd ADR has underperformed by -12.33%,...

Zenas Biopharma Inc (ZBIO) deserves closer scrutiny

While Zenas Biopharma Inc has underperformed by -1.60%, investors...

Zura Bio Ltd (ZURA) produces promising results

While Zura Bio Ltd has underperformed by -3.77%, investors...

How did Anbio Biotechnology (NNNN) fare last session?

While Anbio Biotechnology has overperformed by 8.60%, investors are...

Topics

Can you now get a good deal on Purple Biotech Ltd ADR’s shares?

While Purple Biotech Ltd ADR has underperformed by -12.33%,...

Zenas Biopharma Inc (ZBIO) deserves closer scrutiny

While Zenas Biopharma Inc has underperformed by -1.60%, investors...

Zura Bio Ltd (ZURA) produces promising results

While Zura Bio Ltd has underperformed by -3.77%, investors...

How did Anbio Biotechnology (NNNN) fare last session?

While Anbio Biotechnology has overperformed by 8.60%, investors are...

Is Cibus Inc (CBUS) a threat to investors?

While Cibus Inc has underperformed by -1.47%, investors are...

Can you still get a good price for Aterian Inc (ATER) Shares at this point?

While Aterian Inc has underperformed by -4.28%, investors are...
spot_img

Related Articles

Popular Categories

spot_imgspot_img
US Post News
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.